Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Publication year range
1.
Intern Med ; 50(6): 649-52, 2011.
Article in English | MEDLINE | ID: mdl-21422696

ABSTRACT

A 44-year-old man was referred to our hospital because of persistent high fever. Both CT and PET-CT demonstrated lymph node lesions limited to the mediastinal region without cervical lymphadenopathy. Histology of a mediastinal lymph node obtained by video-assisted thoroscopic excision confirmed the diagnosis of histiocytic necrotizing lymphadenitis. To our knowledge, this is the first report of Kikuchi-Fujimoto disease with isolated mediastinal lymphadenopathy. Although Kikuchi-Fujimoto disease is rare, we should consider this disease in patients with a high fever and no other symptoms.


Subject(s)
Cervical Vertebrae , Histiocytic Necrotizing Lymphadenitis/diagnosis , Lymphatic Diseases/diagnosis , Mediastinal Diseases/diagnosis , Adult , Cervical Vertebrae/pathology , Histiocytic Necrotizing Lymphadenitis/complications , Humans , Lymphatic Diseases/complications , Male , Mediastinal Diseases/complications
2.
Respirology ; 15(8): 1261-5, 2010 Nov.
Article in English | MEDLINE | ID: mdl-20920130

ABSTRACT

Pulmonary fibrosis associated with amyopathic dermatomyositis is known to have a generally aggressive course and is ultimately fatal. We report the case of a 50-year-old patient with amyopathic dermatomyositis, who developed progressive interstitial pneumonia that was unresponsive to corticosteroids and multiple immunosuppressive agents, including cyclosporine and tacrolimus hydrate. Five courses of lecithinized superoxide dismutase were administered without adverse effects. Improvements in physiological parameters, such as pulmonary function and exercise tolerance, as well as the serum Krebs von den Lungen 6 level, were observed. This is the first report of a case of steroid-refractory interstitial pneumonia treated with lecithinized superoxide dismutase.


Subject(s)
Lung Diseases, Interstitial/drug therapy , Phosphatidylcholines/therapeutic use , Superoxide Dismutase/therapeutic use , Adrenal Cortex Hormones/therapeutic use , Cyclosporine/therapeutic use , Dermatomyositis/drug therapy , Exercise Tolerance/drug effects , Humans , Immunosuppressive Agents/therapeutic use , Lung Diseases, Interstitial/diagnostic imaging , Male , Methylprednisolone/therapeutic use , Middle Aged , Mucin-1/blood , Phosphatidylcholines/adverse effects , Prednisolone/therapeutic use , Pulmonary Fibrosis/diagnostic imaging , Pulmonary Fibrosis/drug therapy , Radiography , Respiratory Function Tests , Superoxide Dismutase/adverse effects , Tacrolimus/therapeutic use , Treatment Outcome
3.
Intern Med ; 47(2): 109-12, 2008.
Article in English | MEDLINE | ID: mdl-18195500

ABSTRACT

We report a case of pulmonary adenocarcinoma metastasizing to the adrenal glands, which caused adrenal insufficiency leading to impaired consciousness. A 62 year-old man was admitted with impaired consciousness. The patient started chemotherapy from 2004 for pulmonary adenocarcinoma. In August 2004, a metastatic adrenal tumor was detected and chemotherapy was continued thereafter. From July 2005, the patient started to have mild hyperkalemia, anorexia and general malaise, which progressed to disturbance of consciousness. At admission, physical examination showed generalized pigmentation in the skin and mucosa. Blood test revealed hypoglycemia, hyponatremia and hyperkalemia. A dexamethasone suppression test and a rapid ACTH loading test led to a diagnosis of primary hypoadrenalism (Addison's disease). Treatment with hydrocortisone improved the physical status and blood test values. However, the patient subsequently died of disseminated intravascular coagulation due to the tumor.


Subject(s)
Adenocarcinoma , Adrenal Gland Neoplasms , Adrenal Insufficiency , Lung Neoplasms/pathology , Unconsciousness/etiology , Adenocarcinoma/complications , Adenocarcinoma/secondary , Adrenal Gland Neoplasms/complications , Adrenal Gland Neoplasms/secondary , Adrenal Insufficiency/complications , Adrenal Insufficiency/etiology , Humans , Male , Middle Aged
4.
Allergol Int ; 56(1): 57-65, 2007 Mar.
Article in English | MEDLINE | ID: mdl-17259811

ABSTRACT

BACKGROUND: Galectin-3 is a beta-galactoside-binding protein which is implicated in diverse physiological and pathological processes including human liver cirrhosis and a mouse lung fibrosis model. The aim of this study is to determine whether galectin-3 is involved in human lung fibrosis. METHODS: We measured galectin-3 concentration in bronchoalveolar lavage fluid (BALF) and examined its expression in alveolar macrophages from patients with interstitial lung disorders using ELISA and immunohistochemical staining, respectively. Using monocyte/macrophage cell lines in vitro, we examined the effect of cytokines on galectin-3 expression, and the opposite similarly by RT-PCR and Western blotting. Finally, we performed Micro Boyden chamber assay and Sircoll assay to determine whether galectin-3 induces migration and collagen synthesis, respectively, in fibroblasts. RESULTS: Galectin-3 was specifically increased in BALF from patients with idiopathic pulmonary fibrosis (IPF) and interstitial pneumonia associated with collagen vascular disease (CVD-IP). Galectin-3 levels in BALF seemed to be lower in IPF and CVD-IP patients receiving corticosteroid therapy. Alveolar macrophages from IPF patients expressed more galectin-3 compared with those from control. Galectin-3 expression was induced by tumor necrosis factor-alpha (TNF-alpha) and interferon (IFN)-gamma in a monocytic cell line U937. Galectin-3 also induced mRNA expression and protein production of TNF-alpha and interleukin (IL)-8 in a macrophage cell line THP-1. This lectin stimulated NIH-3T3 fibroblast to induce migration and collagen synthesis in vitro. CONCLUSIONS: These results suggest that galectin-3 is involved in the pathogenesis of human IPF and CVD-IP by activating macrophages and fibroblasts.


Subject(s)
Fibroblasts/metabolism , Galectin 3/metabolism , Macrophages, Alveolar/metabolism , Pulmonary Fibrosis/metabolism , Adrenal Cortex Hormones/therapeutic use , Blotting, Western , Bronchoalveolar Lavage Fluid/chemistry , Bronchoalveolar Lavage Fluid/cytology , Cell Movement/physiology , Collagen/biosynthesis , Enzyme-Linked Immunosorbent Assay , Fibroblasts/immunology , Fluorescent Antibody Technique , Humans , Immunohistochemistry , Lung Diseases, Interstitial/drug therapy , Lung Diseases, Interstitial/metabolism , Macrophage Activation/physiology , Macrophages, Alveolar/immunology , Pulmonary Fibrosis/immunology , Reverse Transcriptase Polymerase Chain Reaction , Vascular Diseases/drug therapy , Vascular Diseases/metabolism
5.
Gan To Kagaku Ryoho ; 33(4): 493-5, 2006 Apr.
Article in Japanese | MEDLINE | ID: mdl-16612159

ABSTRACT

A 79-year-old man was admitted to our hospital with right hypochondrium pain. His chest X-ray and CT scan showed a mass lesion on the left upper lobe, and multiple metastases in the liver. The diagnosis was non-small cell carcinoma of the lung. He received 4 courses of combined chemotherapy of carboplatin and docetaxel every 4 weeks. At the end of 4 courses, a partial response was achieved. Two courses of a in similar regimen were added at the time of a later recurrence, and the effect was a partial response. Carboplatin+docetaxel combined chemotherapy, which can be conducted relatively safely on an outpatient basis, may be an effective treatment for non-small cell lung cancer in the elderly.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Carcinoma, Non-Small-Cell Lung/drug therapy , Lung Neoplasms/drug therapy , Aged , Carboplatin/administration & dosage , Carcinoma, Non-Small-Cell Lung/secondary , Docetaxel , Drug Administration Schedule , Humans , Liver Neoplasms/secondary , Lung Neoplasms/pathology , Male , Quality of Life , Taxoids/administration & dosage
6.
Nihon Kokyuki Gakkai Zasshi ; 44(3): 178-84, 2006 Mar.
Article in Japanese | MEDLINE | ID: mdl-16617860

ABSTRACT

A 75-year-old man was transferred to our hospital on November 28, 2003 because of acute aggravation while being treated for interstitial pneumonia superimposed on pneumoconiosis at a local hospital. Upon admission, oxygen inhalation therapy and antimicrobial chemotherapy were started for the interstitial pneumonia. In addition, since he showed hyponatremia from admission, a saline load was administered and the clinical course was observed. However, disturbance of consciousness developed on January 5, 2004. At that time, the serum sodium was 115mEq/l. Since secretion of antidiuretic hormone (SIADH) had continued despite a low plasma osmolarity, we diagnosed syndrome of inappropriate secretion of antidiuretic hormone (SIADH). We initiated treatment with water restriction and saline load, but no remarkable improvement was observed. From February 7, 40mg /day prednisolone was started because of aggravation of interstitial pneumonia. As a result, the respiratory status and image findings improved, and serum sodium level was normalized. This case was considered to be SIADH secondary to interstitial pneumonia. Among respiratory tract diseases, SIADH is often caused by small cell lung carcinoma, although it may also occur concurrently with other respiratory tract diseases. Since hyponatremia may manifest grave disturbance of consciousness, investigation of the cause is important.


Subject(s)
Inappropriate ADH Syndrome/diagnosis , Inappropriate ADH Syndrome/etiology , Lung Diseases, Interstitial/complications , Aged , Humans , Lung Diseases, Interstitial/diagnostic imaging , Male , Tomography, X-Ray Computed
SELECTION OF CITATIONS
SEARCH DETAIL
...